Trial intelligence / Profile preview

MSC Secretome for Cognitive Recovery in Subacute Ischemic Stroke

NCT07731087Recruiting

Sponsor
Inggit Medical Centre
Start
Jul 2026
Primary completion
Nov 2026
Countries
1
01

Overview

Randomised, single-blind trial in ischemic stroke and cognitive impairment comparing MSC Secretome Plus Standard of Care with Standard of Care Alone (2 arms). Primary endpoint: Montreal Cognitive Assessment-Indonesian Version Total Score at week 8. Started Jul 2026; status: recruiting.

02

Drugs

human umbilical cord mesenchymal stem cell secretome
03

Conditions

ischemic strokecognitive impairment

Beyond the preview

Go deeper on NCT07731087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07731087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call